Search

Santa Farma executes a toll manufacturing agreement with Japanese pharmaceutical giant Astellas

Santa Farma will manufacture Astellas’ product for urinary system disorders in its new manufacturing plant in Dilovası. 

Santa Farma, one of the most deep-rooted and robust domestic pharmaceutical companies in Turkey, agreed to collaborate with Astellas, a leading Japanese pharmaceutical company. As part of this collaboration, Santa Farma Manufacturing Centre, which was commissioned in GEBKİM OIZ with an investment worth EUR 150 million in 2015, will undertake domestic manufacturing of Astellas’ product for urinary system disorders. 

Founded in 1923, Astellas operates in 50 countries throughout the world by means of several therapeutic products for oncology, urology, neurology and the like. Santa Farma, on the other hand, has adopted toll manufacturing as one of the main business fields after commissioning Santa Farma manufacturing plant and R&D centre on a land of 80 thousand sqm in Dilovası GEBKİM OIZ and accordingly, it will manufacture the innovative products of Astellas in its manufacturing plant that holds the EU Good Manufacturing Practices (GMP) compliance certificate. Santa Farma intends to become the manufacturing hub for the products of Astellas in Europe in the long term under this collaboration.

Mr. Erol Kiresepi, Santa Farma President & CEO, making a statement about the collaboration, said: “Our vision for domestic toll manufacturing has begun to turn into reality as a result of our investments. We are truly proud and pleased that we have added another globally important customer to our portfolio thanks to our manufacturing plant equipped with state-of-the-art machinery and the meticulous efforts of our team. We aim to ensure that leading global pharmaceutical companies have their products manufactured in Turkey with the help of our new and modern plant.”